14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
EHC vs FMS: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 20, 2026, Encompass Health Corporation (EHC) is the stronger overall head-to-head candidate over Fresenius Medical Care AG (FMS) in the Tradestie Institutional Equity Comparison Engine, winning 7–2 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Options & Positioning). EHC carries a Unified Composite Score of 52.0/100 (HOLD) at $133.65 (19.4x Forward P/E, 18.4% operating margin), whereas FMS carries 44.7/100 (HOLD) at $20.44 (8.7x Forward P/E, 10.1% operating margin).
Technical & Structure Timing Caution: EHC trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 49.8); meanwhile FMS is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 36.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on EHC vs FMS. Trailing 12-month operating profitability (EHC 18.4% vs FMS 10.1%) and valuation multiples (EHC 19.4x vs FMS 8.7x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Medical Care Facilities value chain with $10.4B market capitalization and 10.1% operating margin.
OpEx & R&D Reinvestment16.4% of Rev ($2.02B)
90D Engineering Disclosures0 Published
Investor FAQ EHC vs FMS Key Questions & Quantitative Answers
As of Nov 20, 2026, Encompass Health Corporation (EHC) is the stronger overall head-to-head candidate over Fresenius Medical Care AG (FMS) in the Tradestie Institutional Equity Comparison Engine, winning 7–2 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Options & Positioning). EHC carries a Unified Composite Score of 52.0/100 (HOLD) at $133.65 (19.4x Forward P/E, 18.4% operating margin), whereas FMS carries 44.7/100 (HOLD) at $20.44 (8.7x Forward P/E, 10.1% operating margin). Technical & Structure Timing Caution: EHC trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 49.8); meanwhile FMS is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 36.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
EHC leads the Growth & Scale pillar: EHC posts +8.9% YoY revenue growth and +21.6% YoY earnings growth on $6.34B TTM revenue (44.1% gross margin, 18.4% operating margin), compared with FMS at +1.1% YoY revenue growth and -35.4% YoY earnings growth on $12.3B TTM revenue (26.5% gross margin, 10.1% operating margin). On trailing 12-month operating scale, EHC generates $6.34B in USD-normalized revenue versus $12.3B for FMS. In operating R&D and SG&A reinvestment, EHC deploys 25.7% of Rev ($1.63B) (0 90-day corporate R&D disclosures) versus 16.4% of Rev ($2.02B) (0 disclosures) for FMS.
FMS screens cheaper on headline valuation multiples. EHC trades at 19.4x Forward P/E, 21.2x Trailing P/E, 0.41x PEG, and 2.5x EV/Revenue (7.2% FCF margin), whereas FMS trades at 8.7x Forward P/E, 11.6x Trailing P/E, 0.92x PEG, and 0.8x EV/Revenue (13.8% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against EHC (25.1% ROE) versus FMS (7.8% ROE) capital efficiency.
In options market volatility and institutional positioning, EHC carries 27.0% implied volatility (8th %ile, Compressed (<25th %ile)), a 0.25x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (-0.10β · 40% Vol realized risk). By comparison, FMS carries 38.4% implied volatility (<1st %ile, Compressed (<25th %ile)), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.03β · 40% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.